The University of Vermont’s Larner College of Medicine features some of the world’s foremost cardiovascular researchers, experts in cardiovascular disease risk factors, thrombosis, atherosclerosis, stroke, and heart failure. the science shared by early-career investigators at the Cardiovascular Research Institute of Vermont’s fourth annual Viridis Montis Challenge, it was apparent that the institution’s reputation and legacy in the field of cardiovascular research will continue to have a global impact.

A new study published in JAMA Cardiology by UVM cardiovascular medicine fellow Margaret Infeld, M.D., M.S., and colleagues found evidence that by implementing a tailored acceleration of heart rates, they could reduce congestion and improve the circulation of blood in heart failure patients with "stiff" hearts.

Vermont Center on Behavior and Health members Stacey Sigmon, Ph.D., and Sherrie Khadanga, M.D., will be recognized at the University of Vermont Larner College of Medicine's Celebration of Gender Equity in Medicine and Science. Dr. Sigmon is the 2023 recipient of the Gender Equity Outstanding Achievement in Medicine and Science Award, and Dr. Khadanga is the winner of the 2023 Rising Star Emerging Professional Award.

Sherrie Khadanga, M.D., M.S., assistant professor of medicine at UVM's Larner College of Medicine and assistant director of cardiac rehabilitation at the UVM Medical Center, was recently featured in a UVM Health Network HealthSource blog post titled "Women Find Strength with Cardiac Rehab" that focused on how High-Intensity Interval Training (HIIT) exercise can help women's recovery after a cardiac event.

(FEBRUARY 11, 2023) Mary Cushman, M.D., M.Sc., professor of medicine and director of the thrombosis and hemostasis program at the UVM Medical Center, recently spoke with The American Journal of Managed Care about racial trends in pulmonary embolism treatment and potential improvements compared with pre-pandemic trends.

Funding Announcement: To encourage and support early-stage, independent investigators in developing high quality and competitive cardiovascular research programs. Investigation must be related to cardiovascular diseases and can be basic, clinical, translational, epidemiologic or public health-related, and includes stroke.